The kinetic parameters for release of fibrinopeptide A (EPA) from human fibrinogen by thrombin are: Km -2.3 x 1O-6M and Vm,,, = 1.1 x 10-10mol of FPA/s per unit of thrombin; for fibrin formation, Km is similar to that for FPA release, but, under the conditions of the present study, Vm.. was approximately half of that for FPA release.
The kinetic parameters for release of fibrinopeptide A (EPA) from human fibrinogen by thrombin are: Km -2.3 x 1O-6M and Vm,,, = 1.1 x 10-10mol of FPA/s per unit of thrombin; for fibrin formation, Km is similar to that for FPA release, but, under the conditions of the present study, Vm.. was approximately half of that for FPA release.
The formation of fibrin polymer before the sol-gel transition was studied by gel-permeation chromatography combined with effluent analysis for fibrinogen antigen and residual FPA. Polymer formation in purified fibrinogen incubated with thrombin proceeded as a bimolecular association of exposed sites in a manner predicted by probability calculations and assuming random FPA cleavage. Each oligomer consisted of n molecules of fibrin monomer and two fibrinogen molecules, each of the latter lacking one FPA molecule, i.e. each oligomer, regardless of molecular size, retains two FPA molecules. The addition of 5 mM-CaCl2 to the reaction mixture changed the rate of polymer formation, so that dimer was no longer the prevalent oligomer; in the presence of Ca2+, the trimer was the oligomer in highest concentration. The polymers formed in the presence of calcium were similar in composition to those without, i.e. 2mol of FPA/mol of oligomer. EDTA-treated plasma samples incubated for short periods of time, 30 s or less, with thrombin ranging in concentration up to 1 N.I.H. unit/ml did not form clots during the 10-15min period of observation until they were applied to the column, though a large proportion of the available FPA was cleaved (maximum 45%).
The soluble polymers in plasma were mostly of the high-M, variety (tetramer and greater); these high-M, polymers contained less than 2mol of FPA/mol of polymer, whereas dimer and trimer in plasma were similar to those in the purified systems, i.e. 2 mol of FPA/mol.
The formation of fibrin from fibrinogen activated by thrombin is a stepwise reaction that is generally understood in qualitative terms, but less is known of quantitative relationships and kinetics. The release of FPA and FPB was described by Blomback & Vestermark (1957) , who estimated a Km for thrombin release of FPA to be approx. 5 pM (Hogg & Blomback, 1974); Nossel et al. (1976) found a roughly similar value, namely 2.99,UM. Others have found higher values (Hermans & McDonagh, 1982) . Release of FPB is initially very much slower, but the rate increases substantially with fibrin polymerization (Hurlet-Jensen et al., 1982) .
The product of proteolysis is fibrin monomer (fibrinogen lacking both FPA molecules) or des-A-fibrinogen (fibrinogen lacking one FPA molecule); these products polymerize, forming first the dimer and then higher oligomers, by forming end-to-end aggregates with an overlap of half a molecule (Hermans & McDonagh, 1982) . The kinetics of fibrin assembly have been studied by Hantgan & Hermans (1979) by means of light-scattering; they concluded that end-to-end association occurred as a bimolecular association of bifunctional monomers, and that the rate constants for end-to-end association was the same for two monomers, monomer-oligomer or oligomer-oligomer. Their data also showed no difference whether fibrinogen was activated by thrombin or reptilase, which only cleaves EPA. Smith (1979) , in a recent N-terminal study of oligomers formed during fibrinogen-fibrin conversion, found that the dimer consisted of two associated des-A-fibrinogen molecules and that each oligomer molecule consisted of n molecules of monomer and two molecules of des-A-fibrinogen. Both Hantgan & Hermans (1979) and Smith (1979) Fibrinogen was dissolved in 60mM-Tris/80mM-NaCl (pH 7.4)/soya-bean trypsin inhibitor (0.2 mg/ ml); except where noted, the fibrinogen concentration was 20mg/ml. If Ca2+ was required, 0.5 MCaCl2 was added in appropriate amount. Thrombin (100 units/ml) was added, except where noted, to a final concentration of 0.1 unit/ml, and the mixture incubated at 250 C. Samples were removed at timed intervals and added to hirudin, such that hirudin was in 5-fold excess over thrombin. Samples were chromatographed immediately or kept frozen at -200C until chromatography. A single freeze-thaw cycle did not alter chromatographic findings.
Complexes in plasma were prepared by adding thrombin (100 units/ml) to plasma [anticoagulated with EDTA (1.5 mg/ml of blood)] to final concentrations of 0.25, 0.5, 0.75 and 1 unit/ml. After 30s, hirudin was added in 5-fold excess. Thrombintreated plasma samples were chromatographed 10-15min after the addition of thrombin; no clots were observed under these conditions. Gel-permeation chromatography was performed on columns (80 cm x 2.5 cm) of Bio-Gel SM equilibrated and eluted with 60mM-Tris/0.3M-NaCl buffer, pH 7.4, with 1Omg of soya-bean trypsin inhibitor per litre. Elution was by gravity feed at a-flow rate of 15-30ml/h. Fractions (5-7 ml) were collected and the effluent volume was determined by weighing every fourth tube before and after fraction collection. A portion (3 ml) of fibrinogen/thrombin reaction mixture was applied to the column in a closed system, and effluent fractions were assayed: (1) by measurement of A280, the readings being converted into ,ug of fibrinogen equivalents/ml by the value AI m = 16.7 (Mosesson et al., 1967) ; (2) by immunoassay in the Technicon immunoprecipitator with the use of goat antiserum to human fibrinogen. The data were expressed as ug of fibrinogen equivalents/ml of effluent, extrapolated from a dilution series of purified fibrinogen of known concentration run simultaneously; and (3) by radioimmunoassay of residual FPA, released by treating a portion with thrombin (10 units/ml) for 10min. The assay was performed with the use of kits donated by Mallinckrodt, St. Louis, MO, U.S.A.
The effluent profiles obtained by all three measurements were resolved into individual components by a computer program developed on the basis of chromatographic-plate theory (Alkjaersig et al., 1973) . The column was calibrated by chromatography of purified proteins of known Mr and diffusion coefficient (D20,W). Fig. 1(a) shows the linear relationship between log Mr of globular proteins and KD (partition coefficient) where V0 was 145 ml and V, was 405 ml (determined by chromatography of a freeze-dried preparation of Escherichia coli and sucrose respectively). Fig. 1(b) shows the linear relationship between log D20,W and KD for globular proteins and for fibrinogen and fibrinogen-derived moieties. Fig. 1 (c) shows the linear relationship from Fig. 1 (a) as a broken line, and that for fibrinogen and fibrinogen-derived moieties, which could be independently verified (closed circles). SDS/polyacrylamide-gel electrophoresis was also used to examine all polymers isolated by chromatography; in no instance, under the experimental conditions employed, was ydimerization detected. Assuming that fibrinogenderived moieties are eluted, so that log Mr is linearly related to KD9 Ve values for the various n-mer shown in Fig. 1 (c) (a) could be extrapolated. Curve-peeling of a variety of elution profiles confirmed protein peaks at these elution volumes. A protein peak was seen at 226 ml (KD 0.3), which corresponds to Mr 530000, compatible with a dimer of fragment X (a fibrinogen breakdown product, Mr 270000).
The elution profile of a pure substance on a gel-permeation column is a Gaussian curve described by the formula: where C is the concentration at elution volume V, Cmax is the peak concentration at elution volume VZ, and Np is a constant for a given column, the theoretical number of plates calculated from the elution profiles of purified biophysically defined proteins (Winzor, 1969) .
Results
The kinetic parameters for FPA release from fibrinogen and for fibrin formation were determined. Km was 2.3,M for both reactions and Vmax was 1.1 x 10-10mol/s per unit of thrombin for FPA release, and 5.6 x 10-11 half-mol/s per unit of thrombin for fibrin formation. The fibrinogen concentration ranged from 0.21 to 9.44mg/ml, the thrombin concentration was 0.05 unit/ml, the pH was 7.4 and the ionic strength was 0. 15.
The polymerization that occurred as a consequence of thrombin action on fibrinogen and before sol-gel transformation was demonstrated by analytical gel-permeation chromatography. Human fibrinogen was exposed to human thrombin; portions removed at timed intervals were added to hirudin and analysed on the agarose column (Fig. 2 , lefthand panels). A similar series of reaction mixtures containing 5 mM-Ca2+ is illustrated in Fig. 2 (righthand panels). The control fibrinogen showed a peak at 256ml; this peak was asymmetric and computer analysis showed that 25% of the protein was in the Vol. 213 form of early fibrinogen-breakdown products. This was confirmed by SDS/polyacrylamide-gel electrophoresis of the reduced fibrinogen; 35% of the a-chains were degraded to fragments of Mr 32000-36000. After 6 min in the absence of Ca2+, a dimer was clearly discernible, being eluted just before the fibrinogen peak, and further incubation resulted in other polymer species in addition to the dimer. In the presence of Ca2+ only small amounts of dimer were formed, and polymers were eluted closer to the void volume. Thrombin treatment of polymer fractions released FPA from all polymer species (Fig. 2, 0 Ef'fluent volume (ml) Fig. 2 . Gel-permeation chromatography offibrinogen/thrombin reaction mixtures Column and eluent were the same as in Fig. 1 . Reaction mixtures were human fibrinogen (20 of dry wt/ml), human thrombin (0. 1 unit/mi) and soya-bean trypsin inhibitor (0.2mg/ml) (left-hand panels); the reaction mixtures in the right-hand panels also had 5 mm-CaCI2. The reaction was stopped at the indicated times by addition of a 5-fold excess of hirudin. Effluents were assayed immunologically, for fibrinogen in a Technicon imnmunoprecipitator (e), and for residual fibrinopeptide A (0) after thrombin treatment of the fractions, by a radioimmunoassay. The broken elution curve obtained from the FPA assay (residual FPA content per ml of fraction) yields the data shown in column 5. The resolution into individual components of the elution profiles of one reaction mixture is shown in Fig. 3 .
All the Fig. 2 profiles were analysed as described above, and the data for FPA content per mol of each polymer species, fibrinogen and fragment X are shown in Table 2 Vol. 213 A significant linear relationship (r = 0.972) was demonstrated to exist, in both the presence and absence of Ca2+, between residual FPA, expressed as FPA/pg of fibrinogen equivalents, and chromatographic elution volumes between 160 and 260 ml (KD 0.06-0.45) (result not shown). Fig. 4 summarizes the data from the experiments in Fig. 2 . The rates of FPA release and reduction in intact fibrinogen are not influenced by Ca2+ in the reaction mixture. The formation rates of individual polymer species, however, differ. In the absence of Ca2+ (Fig. 4, 0) , the rate of formation of each polymer was close to that expected if bimolecular reactions and random thrombin action at susceptible sites are assumed; the lines in Fig. 4 were calculated as suggested by Hantgan & Hermans (1979) . In the presence of Ca2+, dimer formation was much less than predicted by these calculations, and higher oligomers were more abundant.
The X-dimer eluted just before the fibrinogen peak was present in low concentration in the starting fibrinogen (2% of total fibrinogen), but., was increased in all samples after thrombin had been added; its concentration did not change with time [mean value 13.7 + 0.6% (S.E.M.), n = 191. Fragment X, which was a contaminant of the starting fibrinogen (25%), was decreased in all thrombintreated mixtures, but there was no correlation with time [mean 14.3 Na+ concentrations induced a prolonged lag phase, but, when clotting started, it proceeded at a more rapid rate than in its absence (result not shown).
Fibrin polymerformation in plasma
Thrombin added to plasma is rapidly inhibited by the plasma inhibitors, with inhibition nearly complete after 4min. These observations suggested that fibrin polymerization in plasma should be studied by use of increasing thrombin concentrations, rather than as a function of time. EDTA/plasma was treated with thrombin in concentrations ranging from 0.25 to 1 unit/ml for 30s, and the reaction mixtures chromatographed in the same manner as illustrated in Fig. 2 . The effluent profiles (not shown) differed from those in Fig. 2 in that mostly high-Mr polymers eluted close to the void volume. None of the reaction mixtures clotted, but, at the two highest thrombin concentrations, part of the fibrinogenderived moieties precipitated on the column; there was an 18% loss at 0.75 unit of thrombin/ml and a 38% loss at 1 unit/ml.
The data obtained by analysis of the elution profiles of thrombin-treated plasma are summarized in Fig. 5 . FPA release was comparable with that of the experiments illustrated in Fig. 3 , but decrease in intact fibrinogen was less for a given degree of FPA release. The addition of thrombin in smaller concentrations for longer periods of time to plasma, anticoagulated with EDTA or citrate, induced late clot formation ( 1Omin after stopping thrombin action), even though FPA release was less than 20%. The relative concentrations of polymers resulting from thrombin action on fibrinogen in plasma also differed from those in the purified system; dimer and trimer were found in low concentrations and pentamer and tetramer in high concentrations. Table 2 Thrombin (units/ml) Fig. 5 . Rates of FPA release, decrease in intact fibrinogen and appearance of oligomers offibrin(ogen) in plasma incubated with thrombin Normal human plasma (collected in EDTA) was incubated for 30s with human thrombin ranging in concentration from 0.25 to 1 unit/ml. The reaction mixtures were chromatographed under conditions similar to those in Fig. 2 , and the elution profiles analysed in the same manner as shown in Fig. 3 and Table 1 . Panel (1) shows release of FPA as a function of thrombin concentration; panel (2) shows the decrease in intact fibrinogen, and subsequent panels (3-6) the proportions of pentamer, tetramer, trimer and dimer at each thrombin concentration.
for similar-sized polymers in purified systems for dimer and trimer, but differ for the more abundant higher-M, polymers.
Discussion
Fibrinogen-fibrin conversion is classically viewed as a three-step reaction (Scheraga & Laskowski, 1957 release from thrombin-treated fibrinogen, but a 10-fold increase in FPB release rate after fibrin I was formed; moreover, light-scattering studies (Hantgan Vol. 213 & Hermans, 1979) showed no difference between thrombin-and reptilase-mediated reactions, though reptilase only released FPA.
During the lag phase, before fibrin gel is formed, activated fibrinogen, lacking one or two FPA molecules, reacts with other similarly activated molecules to form polymer. Hitherto, polymerization has mostly been studied by light-scattering (Hantgan & Hermans, 1979; Ferry et al., 1954; Blomback & Laurent, 1958; Wiltzius et al., 1982) , and most of these studies have employed substrate/ enzyme concentrations where the physical selfassociation reaction is rate-limiting (Hermans & McDonagh, 1982) . In the present study, thrombin was used in low concentration and FPA release was the rate-limiting step, permitting determination of rate of formation of each polymer species. Smith (1979) , who used gel-permeation chromatography for polymer separation before N-terminal analysis, concluded that initially two fibrinogen molecules, each lacking one FPA molecule, associate to form a dimer which retains two FPA molecules; additional thrombin action and FPA release lead to further association into larger polymers. This concept is supported by the present study; from N-terminal analysis, Smith (1979) found the dimer to be composed of two a(Aa)(BfJ)2(y)2 components. (The three pairs of polypeptide chains of fibrinogen are designated Aa, Bf, and y; when the fibrinopeptides have been removed from Aa-and B,f-chains, the chains become a and ,B respectively.) The only alternative that could fit the data would be a dimer of fibrin monomer and fibrinogen, which, for a number of reasons discussed by Smith (1979) , appears untenable. We failed to detect fibrin-monomerfibrinogen dimer when purified fibrin monomer dissolved in 5 M-urea and free of thrombin was added to purified fibrinogen; in each study, fibrin monomer formed fibrin gel and the chromatographic elution pattern of the mixture was identical with that of the original fibrinogen solution.
On the other hand, Olexa & Budzynski (1980) have presented evidence for the existence of binding sites additional to the two N-terminal sites exposed by thrombin. These authors suggest that linear polymer are formed by the binding of one of these additional sites to a thrombin-exposed binding site on another molecule, permitting formation of a fibrin-monomer-fibriniogen dirner, and others (Heene & Matthias, 1973; Kudryk et al., 1974) have shown that fibrinogen binds to an agarose-fibrinmonomer column and fibrin monomer to an agarose-fibrinogen column; however, steric relationships in free solution and under affinity-column conditions may differ.
Assuming end-to-end aggregation and formation of protofibrils as described by Hermans & McDonagh (1982) , a protofibril can be visualized as a series of fibrin-monomer units linked through the sites exposed by FPA release and with a half-activated fibrinogen molecule;lat each end; thus each polymer molecule, regardless of size, should retain two FPA molecules; such a composition is shown in Table 2 . The rate of formation of each oligomer in solutions of fibrinogen and thrombin was predictable, and could be calculated on the basis of probability, assuming random thrombin action at susceptible sites and bimolecular reactions (Hantgan & Hermans, 1979) . In the presence of Ca2 , additional binding sites appeared to play a role, for dimer formation was much less than in its absence, and higher oligomers were more abundant.
It has been assumed that fibrin polymerization in plasma was qualitatively similar to that encountered in purified systems; however, the present study shows both quantitative and qualitative differences.
The soluble polymers that appeared in the column effluents differed from those in the purified system, where, in the absence of Ca2+, dimer was the predominant species and, in the presence of Ca2+, trimer was predominant; in plasma, dimer and trimer only appeared in low concentrations, whereas larger polymers (greater than tetramer) predominated (Fig. 6) . These large-molecular-size polymers were unstable; at least they tended to precipitate on the column, where they were separated from fibrinogen. The size of these large molecules cannot be estimated accurately, since they are essentially eluted in the void volume. If each polymer is similar in composition to polymers in purified systems, i.e.
2 mol of FPA/mol, the mean M, might be of the order of 3 x 106.
The data suggest that thrombin action at susceptible sites is not random in plasmna, and that thrombin has greater affinity for oligomers; as a consequence, more fibrinogen should remain intact than in the purified system. Comparison of Figs. 4 and 5 shows that at the time when approx. 50% of the available FPA had been released in the purified system, only 20% of the fibrinogen remained in intact form, whereas in plasma with the same degree of FPA release, 50% of the fibrinogen was intact. Thus, in the complex milieu of plasma, some mechanism appears to exist that protects the circulating fibrinogen from proteolytic action by thrombin; a possible explanation for this phenomenon is binding of thrombin to oligomer. Seegers et al. (1945) first demonstrated adsorption of thrombin to fibrin; Liu et al. (1979) confirmed the observation and found (i) that the active site is not required for binding, (ii) that the abtsorbed thrombin is to some extent protected from inactivation by plasma inhibitors, thereby increasing thrombin half-life 8-fold over that of free thrombin in plasma, and (iii) that maximal binding is 1 mol of thrombin/ 2mol of fibrin(ogen). Thus thrombin bound to oligomer would still be able to release FPA from fibrinogen but only in close proximity to an existing oligomer. Liu et al. (1980) also found subtle differences in thrombin binding between reaction mixtures with and without Ca2 ; perhaps these differences might explain the differences in rate of formation of individual oligomers (Fig. 4) .
In previous clinical studies, on analysis of patient plasma samples by gel-permeation chromatography, we found a correlation between the concentration of fibrinogen-derived high-M, complexes of Mr higher than that of fibrinogen itself and thromboembolic disease (Fletcher et al., 1977 (Fletcher et al., , 1979 Alkjaersig et al., 1976 Alkjaersig et al., , 1980 . Several possible mechanisms can be invoked to explain the appearance of these high-Mr derivatives: thrombin action on fibrinogen, plasmin action on fibrin, complexing between fibrin proteolysis products and fibrinogen or complexing of either of these moieties with other plasma proteins. The complexes found in patient plasma samples probably arise through several mechanisms, since it is generally assumed that activation of the blood-coagulation system in vivo is accompanied by activation of the fibrinolytic enzyme system. However, thrombin action on fibrinogen plays a significant role in the genesis of the high-Me fibrin(ogen) complexes found in human plasma. Oligomers formed by thrombin action contain FPA (two molecules per molecule of oligomer), whereas those formed by plasmin action on fibrin do not contain FPA.
